Evaluation of the Pharmacodynamic Effects of BIIB122/DNL151 in Participants with LRRK2 mutation-driven Parkinson’s disease (BEACON Study)
Objective: To characterize the biomarker effects of BIIB122/DNL151 in participants with LRRK2 pathogenic mutations diagnosed with Parkinson’s disease (LRRK2-PD). Background: BIIB122/DNL151 is a CNS-penetrant small…Plasma Protein Profiles Reveal Distinct Molecular Signatures in Parkinson’s Disease and Multiple System Atrophy
Objective: We aimed to identify distinct plasma proteins in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA) and evaluate their associations with disease…A Prospective, Observational Study to Identify Biomarkers in Parkinsonian Syndromes (proATYP).
Objective: This is a prospective observational study to identify biomarkers in parkinsonian syndromes. Background: Parkinson’s disease (PD) and atypical parkinsonian syndromes namely progressive supranuclear palsy…Glossography – a novel, computer-vision based technique for assessing and treating involuntary tongue movements in dyskinetic episodes in Parkinson’s disease
Objective: To develop and evaluate a novel deep learning-based computer vision approach for tracking tongue movements in Parkinson's disease (PD) patients with levodopa-induced dyskinesias to…Alpha-Synuclein Preformed Fibrils Increase the Frequency of CXCR3+ B-cells in Early-stage Parkinson’s Disease Patients
Objective: To investigate the effect of a-Syn Preformed Fibrils (PFF) on CXCR3 expression on B-cells in Parkinson’s Disease (PD) patients at early (E-PD, diagnosed less…Determinants of Cognitive Progression in Parkinson’s Disease: A Machine Learning Approach
Objective: To identify clinical and sociodemographic factors associated with cognitive decline (CD) in PD using a Random Forests model, classifying people with PD (PwP) into…The Role of Neuropsychiatric Symptoms in the Diagnosis of Early Parkinson’s Disease: a Systematic Review
Objective: This study aims to evaluate the role of neuropsychiatric symptoms in the diagnosis of Early Parkinson's Disease. Background: Neuropsychiatric symptoms (NPS) are important and…Duration of Illness and Response to Pimavanserin in Parkinson’s Disease Psychosis: Post-Hoc Analysis of Clinical Trial Data
Objective: To examine individual responses to pimavanserin in patients with Parkinson’s disease psychosis (PDP) initiating treatment <6 vs ≥6 months and <12 vs ≥12 months…Characteristics of Visual Hallucinations in Lewy Body Dementia
Objective: To investigate the risk and the content of visual hallucination (VH) among patients with Lewy body dementia (LBD) within the cultural background of Taiwan.…The Impact of Depression on Information Storage, Consolidation and Evocation Processes in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease without Dementia by Deep Brain Stimulation. Descriptive study of the ESDEPARK Scale.
Objective: To identify the clinical correlation between neurocognitive functioning in memory and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that…
- « Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 436
- Next Page »